ATAI Life Sciences NV (STU:9VC)
€ 1.0905 0.1125 (11.5%) Market Cap: 181.10 Mil Enterprise Value: 118.25 Mil PE Ratio: 0 PB Ratio: 1.18 GF Score: 44/100

Q2 2022 ATAI Life Sciences NV Earnings Presentation Transcript

Aug 15, 2022 / 12:30PM GMT
Release Date Price: €4.61 (+3.15%)
Gregory L. Weaver
Atai Life Sciences N.V. - CFO

Presentation
Aug 15, 2022 / 12:30PM GMT

=====================
Corporate Participants
=====================
* Florian Brand
Atai Life Sciences N.V. - Co-Founder, MD & CEO
* Gregory L. Weaver
Atai Life Sciences N.V. - CFO
* Srinivas G. Rao
Atai Life Sciences N.V. - Co-Founder & Chief Scientific Officer
* Stephen B. Bardin
Atai Life Sciences N.V. - CFO

=====================
Conference Call Participants
=====================
* Judah C. Frommer
Crédit Suisse AG, Research Division - Senior Analyst
* Lin Tsai
Jefferies LLC, Research Division - Equity Analyst

=====================
-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot